Curis
CRIS
#10252
Rank
NZ$40.45 M
Marketcap
NZ$1.01
Share price
-2.15%
Change (1 day)
-61.89%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.24. In 2024 the company made an earnings per share (EPS) of NZ-$11.95 an increase over its 2023 EPS that were of NZ-$15.36.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-46.61%
2024NZ-$11.95-22.15%
2023NZ-$15.36-26.17%
2022NZ-$20.8022.3%
2021NZ-$17.01-25.37%
2020NZ-$22.79-30.93%
2019NZ-$32.99-2.02%
2018NZ-$33.67
2016NZ-$76.52-10%
2015NZ-$85.03138.1%
2014NZ-$35.7140%
2013NZ-$25.51-25%
2012NZ-$34.0166.67%
2011NZ-$20.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.31-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.88-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$4.91-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.61 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.11 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.40-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA